MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6

Shu Mei Chen, Hua Chien Chen, Shu Jen Chen, Chiung Yin Huang, Pin Yuan Chen, Tai Wei Erich Wu, Ly Ying Feng, Hong Chieh Tsai, Tai Ngar Lui, Chuen Hsueh, Kuo Chen Wei

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Glioblastoma multiforme (GBM) is the most aggressive type of glioma and carries the poorest chances of survival. There is therefore an urgent need to understand the mechanisms of glioma tumorigenesis and develop or improve therapeutics. The aim of this study was to assess the possible prognostic value of cyclin-dependent kinase 6 (CDK6) and the effects of microRNA-495 (miR-495) manipulation on CDK6 expression and cell survival in glioma cells.Methods: Analyses of clinical specimens from GBM patients were used. Expression of CDK6 was analyzed by real-time polymerase chain reaction (RT-PCR), Western blotting, and immunohistochemistry. Expression of CDK6 was also analyzed after over-expression of miR-495 in T98 cells; both cell proliferation and RB phosphorylation were examined. Cell proliferation, cell cycle distribution, and RB phosphorylation were also examined after knockdown of CDK6 in U87-MG and T98 cells.Results: Analyses of clinical specimens from GBM patients identified that CDK6 is significantly expressed in gliomas. CDK6 antigen expression was higher in tumor cores and margins than in adjacent normal brain tissues, and higher levels of CDK6 expression in the tumor margin correlated with decreased survival. Over-expression of miR-495 in T98 cells downregulated the expression of CDK6 and inhibited retinoblastoma phosphorylation, and knockdown of CDK6 in U87-MG and T98 cells by siRNAs resulted in cell cycle arrest at the G1/S transition and inhibition of cell proliferation.Conclusions: This study revealed miR-495 is down-regulated in glioma tissues. Furthermore, miR-495 regulated CDK6 expression and involved in glioma cell growth inhibition, which indicated the possible role of miR-495 in tumor progression.

Original languageEnglish
Article number87
JournalWorld Journal of Surgical Oncology
Volume11
DOIs
Publication statusPublished - Apr 17 2013

Fingerprint

Cyclin-Dependent Kinase 6
Glioblastoma
MicroRNAs
Down-Regulation
Glioma
Phosphorylation
Cell Proliferation
G1 Phase Cell Cycle Checkpoints
Neoplasms
Survival
Retinoblastoma

Keywords

  • CDK6
  • Glioblastoma multiforme
  • MicroRNA-495
  • Tumor progression

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6. / Chen, Shu Mei; Chen, Hua Chien; Chen, Shu Jen; Huang, Chiung Yin; Chen, Pin Yuan; Wu, Tai Wei Erich; Feng, Ly Ying; Tsai, Hong Chieh; Lui, Tai Ngar; Hsueh, Chuen; Wei, Kuo Chen.

In: World Journal of Surgical Oncology, Vol. 11, 87, 17.04.2013.

Research output: Contribution to journalArticle

Chen, Shu Mei ; Chen, Hua Chien ; Chen, Shu Jen ; Huang, Chiung Yin ; Chen, Pin Yuan ; Wu, Tai Wei Erich ; Feng, Ly Ying ; Tsai, Hong Chieh ; Lui, Tai Ngar ; Hsueh, Chuen ; Wei, Kuo Chen. / MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6. In: World Journal of Surgical Oncology. 2013 ; Vol. 11.
@article{895bfe6880dc47e9954528ae715d3205,
title = "MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6",
abstract = "Background: Glioblastoma multiforme (GBM) is the most aggressive type of glioma and carries the poorest chances of survival. There is therefore an urgent need to understand the mechanisms of glioma tumorigenesis and develop or improve therapeutics. The aim of this study was to assess the possible prognostic value of cyclin-dependent kinase 6 (CDK6) and the effects of microRNA-495 (miR-495) manipulation on CDK6 expression and cell survival in glioma cells.Methods: Analyses of clinical specimens from GBM patients were used. Expression of CDK6 was analyzed by real-time polymerase chain reaction (RT-PCR), Western blotting, and immunohistochemistry. Expression of CDK6 was also analyzed after over-expression of miR-495 in T98 cells; both cell proliferation and RB phosphorylation were examined. Cell proliferation, cell cycle distribution, and RB phosphorylation were also examined after knockdown of CDK6 in U87-MG and T98 cells.Results: Analyses of clinical specimens from GBM patients identified that CDK6 is significantly expressed in gliomas. CDK6 antigen expression was higher in tumor cores and margins than in adjacent normal brain tissues, and higher levels of CDK6 expression in the tumor margin correlated with decreased survival. Over-expression of miR-495 in T98 cells downregulated the expression of CDK6 and inhibited retinoblastoma phosphorylation, and knockdown of CDK6 in U87-MG and T98 cells by siRNAs resulted in cell cycle arrest at the G1/S transition and inhibition of cell proliferation.Conclusions: This study revealed miR-495 is down-regulated in glioma tissues. Furthermore, miR-495 regulated CDK6 expression and involved in glioma cell growth inhibition, which indicated the possible role of miR-495 in tumor progression.",
keywords = "CDK6, Glioblastoma multiforme, MicroRNA-495, Tumor progression",
author = "Chen, {Shu Mei} and Chen, {Hua Chien} and Chen, {Shu Jen} and Huang, {Chiung Yin} and Chen, {Pin Yuan} and Wu, {Tai Wei Erich} and Feng, {Ly Ying} and Tsai, {Hong Chieh} and Lui, {Tai Ngar} and Chuen Hsueh and Wei, {Kuo Chen}",
year = "2013",
month = "4",
day = "17",
doi = "10.1186/1477-7819-11-87",
language = "English",
volume = "11",
journal = "World Journal of Surgical Oncology",
issn = "1477-7819",
publisher = "BioMed Central",

}

TY - JOUR

T1 - MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6

AU - Chen, Shu Mei

AU - Chen, Hua Chien

AU - Chen, Shu Jen

AU - Huang, Chiung Yin

AU - Chen, Pin Yuan

AU - Wu, Tai Wei Erich

AU - Feng, Ly Ying

AU - Tsai, Hong Chieh

AU - Lui, Tai Ngar

AU - Hsueh, Chuen

AU - Wei, Kuo Chen

PY - 2013/4/17

Y1 - 2013/4/17

N2 - Background: Glioblastoma multiforme (GBM) is the most aggressive type of glioma and carries the poorest chances of survival. There is therefore an urgent need to understand the mechanisms of glioma tumorigenesis and develop or improve therapeutics. The aim of this study was to assess the possible prognostic value of cyclin-dependent kinase 6 (CDK6) and the effects of microRNA-495 (miR-495) manipulation on CDK6 expression and cell survival in glioma cells.Methods: Analyses of clinical specimens from GBM patients were used. Expression of CDK6 was analyzed by real-time polymerase chain reaction (RT-PCR), Western blotting, and immunohistochemistry. Expression of CDK6 was also analyzed after over-expression of miR-495 in T98 cells; both cell proliferation and RB phosphorylation were examined. Cell proliferation, cell cycle distribution, and RB phosphorylation were also examined after knockdown of CDK6 in U87-MG and T98 cells.Results: Analyses of clinical specimens from GBM patients identified that CDK6 is significantly expressed in gliomas. CDK6 antigen expression was higher in tumor cores and margins than in adjacent normal brain tissues, and higher levels of CDK6 expression in the tumor margin correlated with decreased survival. Over-expression of miR-495 in T98 cells downregulated the expression of CDK6 and inhibited retinoblastoma phosphorylation, and knockdown of CDK6 in U87-MG and T98 cells by siRNAs resulted in cell cycle arrest at the G1/S transition and inhibition of cell proliferation.Conclusions: This study revealed miR-495 is down-regulated in glioma tissues. Furthermore, miR-495 regulated CDK6 expression and involved in glioma cell growth inhibition, which indicated the possible role of miR-495 in tumor progression.

AB - Background: Glioblastoma multiforme (GBM) is the most aggressive type of glioma and carries the poorest chances of survival. There is therefore an urgent need to understand the mechanisms of glioma tumorigenesis and develop or improve therapeutics. The aim of this study was to assess the possible prognostic value of cyclin-dependent kinase 6 (CDK6) and the effects of microRNA-495 (miR-495) manipulation on CDK6 expression and cell survival in glioma cells.Methods: Analyses of clinical specimens from GBM patients were used. Expression of CDK6 was analyzed by real-time polymerase chain reaction (RT-PCR), Western blotting, and immunohistochemistry. Expression of CDK6 was also analyzed after over-expression of miR-495 in T98 cells; both cell proliferation and RB phosphorylation were examined. Cell proliferation, cell cycle distribution, and RB phosphorylation were also examined after knockdown of CDK6 in U87-MG and T98 cells.Results: Analyses of clinical specimens from GBM patients identified that CDK6 is significantly expressed in gliomas. CDK6 antigen expression was higher in tumor cores and margins than in adjacent normal brain tissues, and higher levels of CDK6 expression in the tumor margin correlated with decreased survival. Over-expression of miR-495 in T98 cells downregulated the expression of CDK6 and inhibited retinoblastoma phosphorylation, and knockdown of CDK6 in U87-MG and T98 cells by siRNAs resulted in cell cycle arrest at the G1/S transition and inhibition of cell proliferation.Conclusions: This study revealed miR-495 is down-regulated in glioma tissues. Furthermore, miR-495 regulated CDK6 expression and involved in glioma cell growth inhibition, which indicated the possible role of miR-495 in tumor progression.

KW - CDK6

KW - Glioblastoma multiforme

KW - MicroRNA-495

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=84876085532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876085532&partnerID=8YFLogxK

U2 - 10.1186/1477-7819-11-87

DO - 10.1186/1477-7819-11-87

M3 - Article

C2 - 23594394

AN - SCOPUS:84876085532

VL - 11

JO - World Journal of Surgical Oncology

JF - World Journal of Surgical Oncology

SN - 1477-7819

M1 - 87

ER -